Categories AlphaGraphs, Earnings, Health Care
Highlights of Abbott Laboratories (ABT) Q4 2024 results
Abbott Laboratories (NYSE: ABT) on Wednesday announced financial results for the fourth quarter of 2024, reporting an increase in sales and adjusted profit.
Total reported sales increased 7.2% year-over-year to $10.9 billion in the December quarter. Organic sales for the underlying base business grew 10.1%.
Adjusted earnings moved up to $1.34 per share in Q4 from $1.19 per share in the year-ago quarter and matched Wall Street’s expectations. Unadjusted profit rose sharply to $9.23 billion or $5.27 per share in the fourth quarter from $1.60 billion or $0.91 per share in Q4 2023, reflecting a significant tax benefit.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
What Starbucks’ ongoing restructuring means for customers and investors
Starbucks Corporation (NASDAQ: SBUX) has launched an extensive restructuring to streamline operations and optimize customer experience. While navigating a difficult operating environment, the coffee giant is working to revive its
Dollar Tree (DLTR) 4Q24 earnings: Family Dollar sale takes center stage in quarterly report
Shares of Dollar Tree, Inc. (NASDAQ: DLTR) were up over 4% on Wednesday following the announcement of the company’s fourth quarter 2024 earnings results. The top and bottom line numbers
Key metrics from Chewy’s (CHWY) Q4 2024 earnings results
Chewy, Inc. (NYSE: CHWY) reported its fourth quarter 2024 earnings results today. Net sales of $3.25 billion were up 14.9% year-over-year. Net income fell 29% to $22.8 million, or $0.05
